Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
But the company expects growth to accelerate as a result of this strategic pivot in its weight loss business and executives expect Hims & Hers to hit its target of at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030
GLP-1 medications are not substitutes for prescribed medical treatment
Clinical trials show it can lead to significant weight loss when used alongside gentle changes to food and movement (Koman et al., 2024)
Overactive Thyroid (hyperthyroidism)
US$ 23.52
US$ 25.29
US$ 20.75
US$ 21.26
US$ 23.49
US$ 24.91
US$ 20.05
US$ 27.92
